| typ : |
Czasopismo |
|
| Zespoły badawcze : |
Callaghan - School of Pharmacy and Medical Sciences |
| Autorzy : |
Sharley NA, Yu AMC, Williams DB. |
| Tytuł : |
Stability of mixtures formulated from warfarin tablets or powder. |
| Numer : |
J Pharm Pract and Res ; 37: 95-97. 2007 |
|
| Poziom wiarygodności : |
|
| stabilność fizyczną : |
|
| Stabilność chemiczna : |
|
| Inne metody : |
|
| Komentarze : |
|
Listy
 Warfarin sodium
|
 |
 |
 |
 |
300 mg
Coumadin® |
| Fosforan sodu |
3000 mg |
| Tragakant |
4% 60 ml |
| Syrop sorbitolu |
5% 75 ml |
| Metyloparaben |
240 mg |
| Propyloparaben |
60 mg |
| Glikol propylenowy |
3 ml |
| Woda destylowana |
>> 300 ml |
|
20-24°C |
 |
| 28 |
 |
|
|
|
|
|
300 mg
Marevan® |
| Fosforan sodu |
3000 mg |
| Tragakant |
4% 60 ml |
| Syrop sorbitolu |
5% 75 ml |
| Metyloparaben |
240 mg |
| Propyloparaben |
60 mg |
| Glikol propylenowy |
3 ml |
| Woda destylowana |
>> 300 ml |
|
20-24°C |
|
| 28 |
|
|
|
|
|
Warfarin sodium clathrate
|
|
|
|
 |
324.3 mg
Warfarin sodium clathrate |
| Fosforan sodu |
3000 mg |
| Metyloparaben |
240 mg |
| Propyloparaben |
60 mg |
| Glikol propylenowy |
3 ml |
| Woda destylowana |
>> 300 ml |
|
20-24°C |
|
| 28 |
|
|
|
|
|
